NewsBenzinga웰스파고, 유넘 그룹 투자의견 ‘비중확대’ 유지···목표주가 91달러로 하향 조정 웰스파고, 유넘 그룹 투자의견 ‘비중확대’ 유지···목표주가 91달러로 하향 조정 Benzinga 2026.11.12 14:04 (GMT+0) Open on Benzinga Other news Canaccord Genuity Maintains Buy on Belite Bio, Raises Price Target to $314 Applied Optoelectronics Stock Sinks Amid AI Outlook Fears Canaccord Genuity Maintains Buy on Enovix, Lowers Price Target to $2.5 Canaccord Genuity Maintains Buy on Intuitive Machines, Lowers Price Target to $38 'A Zelle representative said that a technical issue on its platform originated with Chase' -NBC Report Canaccord Genuity Maintains Buy on Nektar Therapeutics, Lowers Price Target to $149
'A Zelle representative said that a technical issue on its platform originated with Chase' -NBC Report